BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) will present at the Cancer Immunotherapy: A Long Awaited Reality conference taking place on October 21, 2010, at the New York Academy of Medicine in New York.
Stephen M. Simes, BioSante’s president & chief executive officer, will speak at 11:00 am EDT, and will provide an overview of BioSante’s portfolio of cancer vaccines currently in multiple Phase II clinical trials, as well as comment on the receipt of FDA orphan drug designation received for several of the cancer vaccines.
The agenda for the Cancer Immunotherapy: A Long Awaited Reality conference includes keynotes and plenary discussions, roundtable lunch conversations with experts, a focused science and industry track, as well as networking opportunities. The conference will be hosted by MD Becker Partners and BioBusiness.TV.
Source: BioSante Pharmaceuticals, Inc.
MD Becker Partners